Chan J, Nguyen M, Cheong E, et al. Refractory Mycobacterium genavense infection secondary to thymoma-associated endogenous IL-12 inhibitor. BMJ Neurol Open 2022; 41: e000285. DOI:10.1136/bmjno-2022-000285
The article has been corrected since it was published online. The authors would like to notify that the co-author Dr. Hannah Hu was inadvertently omitted from the authorship list. Dr. Hu is affiliated to Department of Immunology, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
Additionally, the contributors statement has been updated as follows.
Contributors JC contributed to acquisition of data and drafting the manuscript. MN contributed to conception of the work, acquisition of data, analysis and interpretation of data. HH contributed to experiment data and analysis. DSR, EC and SR contributed to conception of the work and interpretation of data. All authors contributed to revision of the manuscript for important intellectual content and approved the version to be published.
